Last reviewed · How we verify

NCT04897373

Active Older Adult Program on Health and Well-being

Completed Last updated 21 May 2021
What this trial tests

trial in Older Adult in 33 participants. Completed in 2 April 2020.

Timeline
7 August 2018
Primary endpoint
2 April 2020
2 April 2020

Quick facts

Lead sponsorMayo Clinic
StatusCompleted
Study typeOBSERVATIONAL
Enrollment33
Start date7 August 2018
Primary completion2 April 2020
Estimated completion2 April 2020
Sites1 location across United States

Conditions studied

Sponsor

Mayo Clinic

Who can join

55 and older, any sex, with Older Adult. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine whether a structured 12-week program designed for older adults will improve physical function and, in parallel, circulating biomarkers of aging

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Exercise reduces circulating biomarkers of cellular senescence in humans.
    Englund DA, Sakamoto AE, Fritsche CM, Heeren AA, et al · · 2021 · cited 95× · PMID 34101960 · DOI 10.1111/acel.13415

Verify or expand the search:

Other recruiting trials for Older Adult

Currently open trials in the same condition.

Other Mayo Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04897373.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing